These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34779277)

  • 21. The emergence of post-COVID-19 mucormycosis in India: Can we prevent it?
    Gupta A; Sharma A; Chakrabarti A
    Indian J Ophthalmol; 2021 Jul; 69(7):1645-1647. PubMed ID: 34146000
    [No Abstract]   [Full Text] [Related]  

  • 22. Online Registry of COVID-19-Associated Mucormycosis Cases, India, 2021.
    Arora S; Hemmige VS; Mandke C; Chansoria M; Rawat SK; Dravid A; Sethi Y; Medikeri G; Jariwala SP; Puius YA;
    Emerg Infect Dis; 2021; 27(11):2963-2965. PubMed ID: 34586056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum.
    Devnath P; Dhama K; Tareq AM; Emran TB
    Int J Surg; 2021 Aug; 92():106031. PubMed ID: 34311126
    [No Abstract]   [Full Text] [Related]  

  • 24. Mucormycosis and COVID-19: Double trouble for India?
    Yasmin F; Najeeb H; Siddiqui SA; Ochani RK
    J Glob Health; 2022; 12():03001. PubMed ID: 35154668
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathogenesis of COVID-19-associated mucormycosis (CAM) in India: probing the triggering factors.
    Arakeri G; Patil S; Rao Us V; Amaral Mendes R; Oeppen RS; Brennan PA
    Br J Oral Maxillofac Surg; 2022 May; 60(4):e533-e534. PubMed ID: 35351328
    [No Abstract]   [Full Text] [Related]  

  • 26. Mucormycosis-A serious threat in the COVID-19 pandemic?
    Szarpak L; Chirico F; Pruc M; Szarpak L; Dzieciatkowski T; Rafique Z
    J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 34029629
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fungal infections in the COVID-19 pandemic, the case of mucormycosis].
    Fernández NB
    Rev Argent Microbiol; 2021; 53(3):181-182. PubMed ID: 34579807
    [No Abstract]   [Full Text] [Related]  

  • 28. Spectrum of intracranial complications of rhino-orbito-cerebral mucormycosis - resurgence in the era of COVID-19 pandemic: a pictorial essay.
    Kaushik KS; Ananthasivan R; Acharya UV; Rawat S; Patil UD; Shankar B; Jose A
    Emerg Radiol; 2021 Dec; 28(6):1097-1106. PubMed ID: 34605991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): a clinical and diagnostic perspective from India.
    Singh K; Kumar S; Shastri S; Sudershan A; Mansotra V
    Immunogenetics; 2022 Apr; 74(2):197-206. PubMed ID: 34596728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fostering a deeper understanding of COVID-19-associated mucormycosis - A commentary on "The mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum" (Int. J. Surg. 2021:106031).
    MohanaSundaram A; Sathanantham ST; Chinchole V; Patil B; Velayutham R
    Int J Surg; 2021 Oct; 94():106110. PubMed ID: 34534704
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pediatric rhino-orbital mucormycosis. First peruvian case in times of the COVID-19 pandemic].
    Meregildo-Rodriguez ED; Espino-Saavedra WG
    Rev Peru Med Exp Salud Publica; 2021; 38(3):472-473. PubMed ID: 34932752
    [No Abstract]   [Full Text] [Related]  

  • 32. The "Black Fungus" in India: The Emerging Syndemic of COVID-19-Associated Mucormycosis.
    Gandra S; Ram S; Levitz SM
    Ann Intern Med; 2021 Sep; 174(9):1301-1302. PubMed ID: 34097436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk of cutaneous mucormycosis associated with COVID-19: A perspective from Pakistan.
    Asri S; Akram MR; Hasan MM; Asad Khan FM; Hashmi N; Wajid F; Ullah I
    Int J Health Plann Manage; 2022 Mar; 37(2):1157-1159. PubMed ID: 34476830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets - Magnifying global pandemic grieve and catastrophe begins.
    Pushparaj K; Kuchi Bhotla H; Arumugam VA; Pappusamy M; Easwaran M; Liu WC; Issara U; Rengasamy KRR; Meyyazhagan A; Balasubramanian B
    Sci Total Environ; 2022 Jan; 805():150355. PubMed ID: 34818767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commentary on "Mucormycosis co-infection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum" (Int J Surg 2021, 92:106031) - A pulmonary perspective.
    Gangakhedkar MR; Gupta R
    Int J Surg; 2021 Oct; 94():106116. PubMed ID: 34537396
    [No Abstract]   [Full Text] [Related]  

  • 36. Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India.
    Mishra Y; Prashar M; Sharma D; Akash ; Kumar VP; Tilak TVSVGK
    Diabetes Metab Syndr; 2021; 15(4):102196. PubMed ID: 34246939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five probable factors responsible for the COVID-associated mucormycosis outbreak in India.
    Ravindra K; Ahlawat A
    Int J Infect Dis; 2021 Nov; 112():278-280. PubMed ID: 34592439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case control investigation of COVID-19 associated mucormycosis in India.
    Anand T; Mukherjee A; Satija A; Velamuri PS; Singh KJ; Das M; Josten K; Yadav PD; Sahay RR; Keche AY; Nagarkar NM; Gupta P; Himanshu D; Mistry SN; Patel JD; Rao P; Rohatgi S; Ghosh S; Hazra A; Kindo AJ; Annamalai R; Rudramurthy SM; Singh MP; Shameem M; Fatima N; Khambholja JR; Parikh S; Madkaikar M; Pradhan VD; Kataria S; Sharma P; Panda S;
    BMC Infect Dis; 2022 Nov; 22(1):856. PubMed ID: 36384482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
    Singh AK; Singh R; Joshi SR; Misra A
    Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.